SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from VOLITIONRX LTD (VNRX) (CIK 0000093314) (VNRX) — Sep 26, 2018

VOLITIONRX LTD (VNRX) (CIK 0000093314)
Date: Sept. 26, 2018 · CIK: 0000093314 · Accession: 0001078782-18-001074

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-227248

Date
September 26, 2018
Author
VOLITIONRX LIMITED
Form
CORRESP
Company
VOLITIONRX LTD (VNRX) (CIK 0000093314)

Letter

Securities and Exchange Commission Division of Corporation Finance Attention: Dorrie Yale Registration Statement on Form S-3 File No. 333-227248 Requested Date:September 28, 2018 Requested Time:5:00 P.M. Eastern Time

Dear Ms. Yale:

Pursuant to Rule 461 of the Securities Act of 1933, as amended (the “Securities Act”), VolitionRx Limited, a Delaware corporation (the “Company”), hereby respectfully requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to declare the above-captioned Registration Statement on Form S-3 effective at the “Requested Date” and “Requested Time” set forth above, or as soon thereafter as practicable.

Should the Commission have any questions regarding this acceleration request, please do not hesitate to contact Marc G. Alcser, an attorney with the Company’s outside legal counsel, Stradling Yocca Carlson & Rauth, P.C., via telephone at (949) 725-4136 or via email at malcser@sycr.com.

Sincerely,
VOLITIONRX LIMITED

Show Raw Text
CORRESP
1
filename1.htm

Acceleration Request

VOLITIONRX LIMITED

1 Scotts Road

#24-05 Shaw Centre

Singapore 228208

September 26, 2018

SUBMITTED VIA EDGAR

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Attention:  Dorrie Yale

Re:VolitionRx Limited Acceleration Request

Registration Statement on Form S-3

File No. 333-227248

Requested Date:September 28, 2018

Requested Time:5:00 P.M. Eastern Time

Dear Ms. Yale:

Pursuant to Rule 461 of the Securities Act of 1933, as amended (the “Securities Act”), VolitionRx Limited, a Delaware corporation (the “Company”), hereby respectfully requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to declare the above-captioned Registration Statement on Form S-3 effective at the “Requested Date” and “Requested Time” set forth above, or as soon thereafter as practicable.

Should the Commission have any questions regarding this acceleration request, please do not hesitate to contact Marc G. Alcser, an attorney with the Company’s outside legal counsel, Stradling Yocca Carlson & Rauth, P.C., via telephone at (949) 725-4136 or via email at malcser@sycr.com.

Sincerely,

VOLITIONRX LIMITED

/s/ Cameron Reynolds

Cameron Reynolds

President and Chief Executive Officer

cc:

Stradling Yocca Carlson & Rauth, P.C.

Marc G. Alcser, Esq.